These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 171464)

  • 21. Demonstration of intratumoral infiltration of tumor-specific Lyt-1+2- T cells mediating delayed-type hypersensitivity response and in vivo protective immunity.
    Tomita S; Fujiwara H; Yamane Y; Sano S; Nakajima H; Izumi Y; Arai H; Kawanishi Y; Tsuchida T; Hamaoka T
    Jpn J Cancer Res; 1986 Feb; 77(2):182-9. PubMed ID: 3082830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NTP Toxicology and Carcinogenesis Studies of Nickel Sulfate Hexahydrate (CAS No. 10101-97-0) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Jul; 454():1-380. PubMed ID: 12587012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in expression and glycosylation pattern of the Thy-1 glycoprotein during maturation and transformation of mouse T lymphocytes.
    Carlsson SR; Stigbrand TI
    J Immunol; 1983 Apr; 130(4):1837-42. PubMed ID: 6131921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deoxyribonucleic acid synthetic response of mouse lymphoid cells in microculture with T-lymphocyte-dependent mitogens.
    Williams RM; Benacerraf B
    Lab Invest; 1975 Mar; 32(3):382-7. PubMed ID: 1079068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA.
    Shouval D; Reid LM; Chakraborty PR; Ruiz-Opazo N; Morecki R; Gerber MA; Thung SN; Shafritz DA
    Cancer Res; 1981 Apr; 41(4):1342-50. PubMed ID: 6260336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel human tumor necrosis factor alfa mutein, F4614, inhibits in vitro and in vivo growth of murine and human hepatoma: implication for immunotherapy of human hepatocellular carcinoma.
    Atarashi Y; Yasumura S; Nambu S; Yoshio Y; Murakami J; Takahara T; Higuchi K; Watanabe A; Miyata K; Kato M
    Hepatology; 1998 Jul; 28(1):57-67. PubMed ID: 9657097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of phagocytic activity of macrophages and their RNA content in mice-tumor carriers and isologous intact mice].
    Aleksanian IuT; Manukian LA; Panosian SG; Karamanukian AK
    Zh Eksp Klin Med; 1974; 14(4):18-22. PubMed ID: 4370847
    [No Abstract]   [Full Text] [Related]  

  • 28. Phenotypic and functional modifications of thymocytes during tumor growth.
    Lombardi D; Naso G; Ottavio L; Lenti L; Mardente S; Pontieri GM
    Thymus; 1992 Feb; 19(1):13-33. PubMed ID: 1566282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of tumor growth on migratory properties of T lymphocytes in rats.
    Klobusická M; Koníková E; Novotná L
    Neoplasma; 1980; 27(6):675-82. PubMed ID: 6973097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistology of lymphoid and non-lymphoid cells in the thymus in relation to T lymphocyte differentiation.
    Van Ewijk W
    Am J Anat; 1984 Jul; 170(3):311-30. PubMed ID: 6332520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state.
    Tada T; Ohzeki S; Utsumi K; Takiuchi H; Muramatsu M; Li XF; Shimizu J; Fujiwara H; Hamaoka T
    J Immunol; 1991 Feb; 146(3):1077-82. PubMed ID: 1671050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of a lymph node metastatic model of mouse hepatocellular carcinoma Hca-F cells in C3H/Hej mice.
    Li HF; Ling MY; Xie Y; Xie H
    Oncol Res; 1998; 10(11-12):569-73. PubMed ID: 10367938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary cytotoxic cell response to lymphocytic choriomeningitis virus. I. Kinetics of induction in vitro and yields of effector cells.
    Dunlop MB; Blanden RV
    Immunology; 1976 Aug; 31(2):171-80. PubMed ID: 955675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of carcinogenic exposure and tumor growth on the sensitization of C3HA mouse lymphoid cells to normal cell antigens].
    Malygin AM; Fel' VIa
    Tsitologiia; 1981 Mar; 23(3):340-5. PubMed ID: 6787763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In situ lymphoid cells of mouse mammary tumors. III. In vitro stimulation of tumor cell survival by lymphoid cells separated from mammary tumors.
    Blazar BA; Miller FR; Heppner GH
    J Immunol; 1978 Jun; 120(6):1887-91. PubMed ID: 659883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of reconstruction of immunological functions of T lymphocytes on mouse hepatocarcinoma metastasis].
    Wang KF; Ye SL; Xue Q; Song LJ; Tian B; Liang CM; Weng YQ; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):443-6. PubMed ID: 15975280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro studies of the rabbit immune system. VI. Rabbit anti-mouse cytotoxic T effector cells are inhibited by anti-rabbit T cell serum in the absence of complement.
    Redelman D; Trefts PE
    J Immunol; 1978 Oct; 121(4):1532-9. PubMed ID: 308967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion of self-reactive T cells in the donor-derived T cells but not in the host-derived T cells in fully allogeneic radiation chimeras. Mls-reactive T cells in allogeneic radiation chimeras.
    Ogimoto M; Yoshikai Y; Matsuzaki G; Ohga S; Matsumoto K; Nomoto K
    Thymus; 1991 Feb; 17(1):11-22. PubMed ID: 1901675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Release of mitogenic factor by mouse lymph node cells stimulated with PHA in vitro. Inhibition of this phenomenon by the addition of thymocytes.
    Jacobsson H; Blomgren H
    J Immunol; 1975 May; 114(5):1623-30. PubMed ID: 1079041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.